PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in Squarepoint Ops LLC  ·  31 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.36% (2015 Q2)
Avg. % of fund
0.02%
First filed
2015 Q2
Last filed
2025 Q3
Quarters held
31
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 21,334 +3,540 +19.9% 0.00% $113K $5.31
2025 Q2 REDUCED 17,794 -58,135 -76.6% 0.00% $61K $3.43
2024 Q4 REDUCED 75,929 -23,318 -23.5% 0.00% $232K $3.05
2024 Q3 ADDED 99,247 +27,856 +39.0% 0.00% $253K $2.55
27 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% C2C Wealth Management, LLC 3Y 0.12% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08%
← Back to Squarepoint Ops LLC Holdings